The Comparison of Cognition, Depression and Anxiety, and Quality of Life After Hip Fracture Surgery Under General or Regional Anesthesia

NCT ID: NCT04518839

Last Updated: 2020-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-31

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative cognitive dysfunction is a relatively common in elderly patients after hip surgery, but exact mechanism of its onset is still unclear as well as contributing factors. There is also increased incidence of depression and anxiety. Both affect the recovery after surgery, slow it down and reduce the quality of life. Patients will be divided into two groups, operated under regional anaesthesia and operated under general anaesthesia, and monitored after surgery. Patients will be tested before and after surgery to evaluate postoperative cognitive deficits, depression and anxiety scale and health-related quality of life questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Cognitive Dysfunction Hip Fractures Depression, Anxiety Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group with regional anaesthesia

No interventions assigned to this group

Group with general anaesthesia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients intended for surgical treatment of hip fractures ≥ 60 years
* Patients who are category ASA I to ASA III will be included in research
* Sufficient cognitive ability
* Only those patients who have agreed to be participants in the research and have signed the consent for participation and informed consent.

Exclusion Criteria

* Patients who refused to participate in the survey and who did not sign informed consent
* Patients with ASA IV or more
* Patients under 60 years
* Severe psychiatric disorders involving the use of psychopharmaceuticals back three months
* All patients who have other fractures in addition to hip fractures
* Polytrauma
* All patients scheduled for more than one surgical intervention during the procedure, or within the next 8 weeks
* Patients who have been diagnosed with dementia, and / or are receiving anti-dementia drugs
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zagreb

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tea Fabijanić, MD

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tea Fabijanić, MD

Role: PRINCIPAL_INVESTIGATOR

University of Zagreb

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tea Fabijanić, MD

Role: CONTACT

00385915698801

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

643-03/20-07/33,380-130/134-20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.